Top
Main
 
All Outcomes
 
Feedback
Home
c19early.org COVID-19 treatment researchHydrogen PeroxideHydrogen Per.. (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

Loading...
More

Supplementary Data — Hydrogen Peroxide for COVID-19: real-time meta analysis of 7 studies

@CovidAnalysis, June 2024, Version 4V4
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Mukhtar (RCT) 86% 0.14 [0.01-2.69] death 0/46 3/46 CT​1 Improvement, RR [CI] Treatment Control Mukhtar (RCT) 86% 0.14 [0.01-2.69] ventilation 0/46 3/46 CT​1 Mukhtar (RCT) 18% 0.82 [0.63-1.07] viral+ 28/43 35/44 CT​1 Mukhtar (RCT) 14% 0.86 [0.76-0.98] viral+ 37/43 44/44 CT​1 Jayaraman 50% 0.50 [0.23-1.08] viral+ 3/6 6/6 Short term viral Pablo-Marcos 12% 0.88 [0.48-1.58] viral load 17 (n) 40 (n) Pablo-Marcos -64% 1.64 [0.83-3.23] viral load 31 (n) 40 (n) Di Domê.. (DB RCT) 50% 0.50 [0.05-5.08] ICU 1/20 2/20 Di Domê.. (DB RCT) 6% 0.94 [0.37-2.38] no improv. 18 (n) 17 (n) Di Domê.. (DB RCT) 7% 0.93 [0.71-1.22] no disch. 18 (n) 17 (n) Di Domê.. (DB RCT) 34% 0.66 [0.10-4.55] ICU 2/77 2/51 Di Domê.. (DB RCT) -1% 1.01 [0.61-1.67] no recov. 63 (n) 43 (n) Di Domê.. (DB RCT) 31% 0.69 [0.24-1.95] PASC 6/51 6/35 HOPE in COVID-19 Agrawal (DB RCT) 67% 0.33 [0.04-2.94] death 1/20 3/20 HOPE in COVID-19 Agrawal (DB RCT) 67% 0.33 [0.04-2.94] ventilation 1/20 3/20 HOPE in COVID-19 Agrawal (DB RCT) 46% 0.54 [0.44-0.66] oxygen time 19 (n) 17 (n) HOPE in COVID-19 Agrawal (DB RCT) 36% 0.64 [0.55-0.75] recov. time 19 (n) 17 (n) HOPE in COVID-19 Agrawal (DB RCT) 39% 0.61 [0.49-0.77] recov. time 19 (n) 17 (n) HOPE in COVID-19 Agrawal (DB RCT) 30% 0.70 [0.57-0.87] recov. time 19 (n) 17 (n) HOPE in COVID-19 Agrawal (DB RCT) 45% 0.55 [0.45-0.67] viral time 19 (n) 17 (n) Amoah 93% 0.07 [0.00-1.13] cases 94 (n) 372 (n) Amoah 93% 0.07 [0.00-1.25] cases 0/94 10/372 Amoah 98% 0.0 [0.00-7e+04] cases 0/8 62/458 Hydrogen peroxide COVID-19 outcomes c19early.org June 2024 1 CT: study uses combined treatment Favors hydrogen peroxide Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit